Your browser doesn't support javascript.
loading
Evaluation of Quality of Life after Surgical Treatment of Thoracic Outlet Syndrome.
Ammi, Myriam; Hersant, Jeanne; Henni, Samir; Daligault, Mickael; Papon, Xavier; Abraham, Pierre; Picquet, Jean.
  • Ammi M; Department of Vascular and Thoracic Surgery, University Hospital, Angers, France. Electronic address: ammimyriam@yahoo.fr.
  • Hersant J; Department of Vascular and Sports Investigations, University Hospital, Angers, France.
  • Henni S; Department of Vascular and Sports Investigations, University Hospital, Angers, France.
  • Daligault M; Department of Vascular and Thoracic Surgery, University Hospital, Angers, France.
  • Papon X; Department of Vascular and Thoracic Surgery, University Hospital, Angers, France.
  • Abraham P; Department of Vascular and Sports Investigations, University Hospital, Angers, France.
  • Picquet J; Department of Vascular and Thoracic Surgery, University Hospital, Angers, France.
Ann Vasc Surg ; 85: 276-283, 2022 Sep.
Article en En | MEDLINE | ID: mdl-35339598
BACKGROUND: To evaluate the quality of life of surgically treated patients for TOS. METHODS: A prospective observational study, including patients treated surgically for TOS in 2018. Two standardized questionnaires: Disability of the Arm, Shoulder, and Hand (DASH) questionnaire and the Short-Form 12 (SF-12) were used. The SF-12 consists of a physical and mental component (PCS-SF-12 and MCS-SF-12). The questionnaires were completed during the preoperative and postoperative consultations and at 3, 6, and 12 months. RESULTS: We performed 53 interventions. The population was mostly female (n = 35, 66.0%) of 40.1 ± 10.0 years. The preoperative DASH score was 46.3 ± 19.7. It was 40.9 ± 21.7 at 6 weeks, 33.5 ± 22.7 at 3 months, 28.9 ± 22.6 at 6 months, and 21.1 ± 20 at 9 to 12 months. The improvement of DASH becomes statistically significant at 3 months (P = 0.036), 6 months (P = 0.002), and 12 months (P = 0.001). The preoperative MCS-SF-12 was 36.6 ± 9.4. It was 41.6 ± 10.9 at 6 weeks, 43.8 ± 11.1 at 3 months, 46.2 ± 11.8 at 6 months, and 51.4 ± 8 at 8 to 12 months. The improvement of MCS-SF-12 became significant at 3 months (P = 0.009), 6 months (P = 0.001), and 12 months (P = 0.001). The preoperative PCS-SF-12 was 35.5 ± 6.4. It was 37.1 ± 8.7 at 6 weeks, 39.9 ± 8.7 at 3 months, 41.6 ± 8.4 at 6 months, and 46.1 ± 8.1 to 12 months. The improvement of PCS-SF-12 became significant at 6 months (P = 0.005) and 12 months (P = 0.001). CONCLUSIONS: The surgical management of TOS allows for an improvement in quality of life in the short and medium terms.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Síndrome del Desfiladero Torácico Tipo de estudio: Observational_studies Límite: Female / Humans / Male Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Síndrome del Desfiladero Torácico Tipo de estudio: Observational_studies Límite: Female / Humans / Male Idioma: En Año: 2022 Tipo del documento: Article